Long intergenic non-protein coding RNA 349 (LINC00349)

Long intergenic non-protein coding RNA 349 (LINC00349) is a long non-coding RNA (lncRNA) gene located on chromosome 13. It is classified as a lincRNA, meaning that it is transcribed but not translated into protein. There is no known protein-coding potential, and no disease, drug, or biomarker associations have been established in major genetics or transcriptomics databases. Its precise biological functions and clinical relevance are currently unknown, as the literature on this transcript is minimal and there are no studies indicating its role as a receptor, enzyme, transporter, or other classical therapeutic target[1][3][5][7]. The designation "long intergenic non-protein coding RNA 349" is the full standardized name according to both HGNC and Ensembl[1][5][7]. LINC00349 is the accepted gene symbol and abbreviation[3][7]. LINC00349 belongs to the class of long non-coding RNAs (lncRNAs), specifically lincRNAs, and has no protein-coding potential by multiple computational criteria[7]. It is located on Chromosome 13: GRCh37/hg19: 19,114,637-19,124,837 / hg38: 18,540,497–18,550,697[5][7]. No evidence was found of LINC00349 being utilized as a therapeutic target, molecular biomarker, or drug-interaction partner in current gene or transcript databases[1][3][5][7]. No human disease roles or safety/efficacy considerations are established. No specific biological function has been established in current literature or databases[1][3][7], and no clear disease association or role identified in existing databases[7].

Other names

LINC00349linc-MPHOSPH8-9XLOC_010283RP11-77P19.2ENSG00000231238OTTHUMG00000016451.1TCONS_00021521LINC00349:1LINC00349-001ENST00000448748ENST00000448748.1OTTHUMT00000043974.1NONHSAT032186[7]